High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) pertains to a hematologic malignancy with heterogeneous therapeutic responses. Improvements in risk stratification in AML patients are warranted. MicroRNAs have been associated with the pathogenesis of AML. Methods To examine the prognostic value of m...

Full description

Bibliographic Details
Main Authors: Mingshan Niu, Yuan Feng, Ninghan Zhang, Tingting Shao, Huihui Zhang, Rong Wang, Yao Yao, Ruosi Yao, Qingyun Wu, Jiang Cao, Xuejiao Liu, Yubo Liu, Kailin Xu
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Cancer Cell International
Subjects:
Acute myeloid leukemia
miR-25
Clinical outcome
Chemotherapy
Allo-HSCT
Online Access:http://link.springer.com/article/10.1186/s12935-019-0843-9

Internet

http://link.springer.com/article/10.1186/s12935-019-0843-9

Similar Items